Polaris Platform Performs First Robotic Cataract Surgery

Horizon Surgical Systems has announced the successful completion of the world’s first robotic cataract surgery performed using its Polaris platform. The procedure was conducted by Uday Devgan, MD, FACS, marking a pivotal milestone in the advancement of robotics and AI in ophthalmic surgery.

Purpose-Built Robotic System for Ophthalmology

The Polaris platform is described as the first surgical system specifically developed for ophthalmology that integrates AI-driven visualization with micro-robotic precision control. According to Horizon, the system is designed to reduce variability across procedures, enhance precision, and seamlessly integrate with current operating room workflows—offering enhanced control for surgeons while preserving procedural familiarity.

“Every cataract patient deserves the same level of safety, precision, and visual outcome, but the reality is that even the best surgeons can encounter subtle inconsistencies across procedures,” said Dr. Devgan. “With Polaris, I experienced a new level of control that directly addresses those challenges. It has the potential to deliver more reliable outcomes for patients while giving surgeons the confidence that every case can be approached with greater consistency.”

First-in-Human Procedure Marks Clinical Start for Polaris Platform

“This first-in-human procedure represents the culmination of more than a decade of innovation and the start of Polaris’ clinical journey,” said Jean Pierre Hubschman, MD, founder and CEO of Horizon Surgical Systems. “Polaris was designed to extend surgeons’ capabilities by delivering greater precision while enhancing safety and efficiency in ophthalmic surgery. Achieving the world’s first successful robotic cataract surgery is a landmark milestone that underscores how robotics and AI can help address some of the most pressing challenges in global eye care.”

The Polaris system is the result of 15 years of research and development, with origins at the University of California, Los Angeles (UCLA). Horizon positions the platform as a scalable solution to improve consistency in cataract surgery outcomes, while helping address the global ophthalmic care gap caused by rising patient volumes and surgeon shortages.

Next Steps Toward FDA Approval and Commercialization

Horizon plans to expand its clinical program in the coming months by treating additional patients and further validating the Polaris platform's performance and safety. The company’s long-term objective includes securing FDA approval and progressing toward commercial availability of the system.